Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Apr 2023 - Mar 2024
Lobbyists (Full time equivalent)
6.25 Fte (7)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
International Drug Policy Consortium (IDPC)
EU Transparency Register
75318797051-52 First registered on 01 Nov 2011
Goals / Remit
IDPC is a a global network of NGOs that come together to amplify and strengthen a diverse global movement to repair the harms caused by punitive drug policies, and promote just responses. Our advocacy positions are based on five core policy principles - drug policies should:
- be developed through an objective assessment of priorities and evidence
- comply with human rights principles, laws and standards
- focus on reducing the harmful consequences, rather than the scale, of drug use and markets
- promote social justice and the inclusion of marginalised groups
- meaningfully involve civil society and affected populations.
IDPC produces briefing papers, disseminates key resources on drug policy, builds the advocacy capacity of our members and partners, and offers expert advice to policy makers and officials around the world. Our global membership has expertise and experience on the wide spectrum of drug policy issues.Main EU files targeted
IDPC is part of the EU Civil Society Forum on Drugs (CSFD). As such, we engage directly in activities aimed at advising and providing recommendations to EU institutions around drug policy issues. IDPC's Head of Research and Communications is a member of the Core Group of the CSFD, coordinating a working group focusing on international drug policy issues.
Individually, IDPC also collaborates with partners to organise seminars and discussions, as well as produce briefing papers and position papers on European drug policies. IDPC holds regular meetings with EU institutions, including the EUDA, Members of European Parliament, the HDG, the European Council, the European Commission (DG Home) and the EEAS. A large part of our advocacy is related to the implementation and evaluation of the EU's Drug Strategy 2021-2025.Address
Head Office
c/o The Transnational InstituteDe Wittenstraat 25
Amsterdam 1052 AK
NETHERLANDSEU Office
c/o The Transnational InstituteDe Wittenstraat 25
Amsterdam 1052 AK
NETHERLANDSWebsite
-
People
Total lobbyists declared
7
Employment time Lobbyists 100% 6 25% 1 Lobbyists (Full time equivalent)
6.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
IDPC staff includes six full time staff members and one part time staff member. We also hire consultants around the world who work on thematic or regional issues related to drug policy. Three members of our staff are regularly in touch with EU institutions. For more information on the IDPC team, please visit: www.idpc.net/team.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
IDPC is a member of the European Civil Society Forum on Drugs, the Vienna NGO Committee on Drugs, the New York NGO Committee on Drugs, the Alliance of NGOs on Crime Prevention and Criminal Justice, as well as CoNGO. IDPC also has ECOSOC Consultative Status.
Member organisations
The full list of our 190+ members per region is available here: http://idpc.net/members
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Apr 2023 - Mar 2024
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
1,812,131€
Major funding types in closed year
Grants
Major contributions in closed year
Type Name Amount Contribution National governments 78,219€ Contribution Open Society Foundations 233,734€ Contribution Robert Carr Fund 832,674€ Contribution UN Agencies 84,153€ Contribution Elton John AIDS Foundation 377,171€ Contribution VOICE 80,412€ Contribution European Commission 13,850€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
Commission expert group - Civil Society Forum on Drugs#E02681#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2681 #MEMBER #C#Civil society
Groups (European Parliament)
N/A
Communication activities
IDPC has a strong publications work stream, which includes detailed reports on global drug policy (all available here: www.idpc.net/publications), which are relevant to the EU's position on the international drug control regime. We also published reports around proportionality of sentencing, decriminalisation, harm reduction and other matters of interest for the EU and its member states.
We also reach out to EU member states and EU institutions (in particular the HDG, the Commission, the Council, the European Parliament, the EEAS and the EUDA) to try and influence their positions around key drug policy matters. We regularly organise expert seminars, informal briefings and bilateral meetings, often in partnership with other NGOs or governments, to discuss strategy and thematic areas, generally on international drug control. These events usually take place in Brussels, in Vienna (where the UN drug control bodies are based), in Geneva (where UN health and human rights bodies are based) or in capitals of key EU countries.
For instance, IDPC provided regular written and oral inputs as the EU was evaluating its Drug Strategy and Action Plan for 2013-2020 and fed into the discussions for the elaboration and evaluation of the new EU Drug Strategy for 2021-2025.
Over the past year, IDPC also engaged in significant advocacy around the renewal of the mandate of the EUDA, through written contributions and side meetings with the HDG, former EMCDDA and MEPs.
We also share critical information about drug control to NGOs and EU member states alike via our monthly newsletter and multilingual website, targeted emails and social media channels.
As part of the CSFD working group on international relations, IDPC coordinated the drafting of a number of detailed recommendations around the UNGASS process, the 2019 Ministerial Segment, the UN Commission on Narcotic Drugs, and now the preparations for the 2024 mid-term review of the 2019 Ministerial Declaration on drugs. Each year, the working group/CSFD is invited to present recommendations at a number of HDG meetings, and at a side event organised by the EU at CND and in other international gatherings.
Finally, we engage with EU institutions as part of the EU's bilateral dialogues and engagement with third parties, providing detailed written inputs ahead of key bilateral dialogues (in particular with Russia, the USA, the Balkans, CELAC and others) and as major human rights issues arise (for example with regards to the Philippines' war on drugs, or the death penalty for drug offences in Singapore).Other activities
None declared
Meetings
Meetings
None declared